Feb 282020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an oncology-focused pharmaceutical company, today announced the appointment of Richard Paulson to its Board of Directors. Mr. Paulson is currently Executive Vice President and Chief Executive Officer of Ipsen North America, a global biopharmaceutical company focused on innovation and specialty care. Prior to joining Ipsen, Mr. ...

Karyopharm Therapeutics welcomes Richard Paulson to its Board of Directors

From:: Karyopharm Therapeutics welcomes Richard Paulson to its Board of Directors

Sorry, the comment form is closed at this time.